Robert Barrow, CEO: Definium Therapeutics DFTX Sell · Filed 24/03/26

Trade details

Type: Insider sale
Amount: $156,930.5
Shares · price: 16,519 sh · $9.50 a share
Held after: 580,202 sh
Stock: Definium Therapeutics DFTX
Person: Robert BarrowCEO
Trade date: 24/03/25
Filed: 24/03/26
Days to filing: 1 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Definium Therapeutics trades, last 26 weeks

What else happened in Definium Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/24~24/04/24

Robert Barrow's recent trades

Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/29
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/25
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$718.1K
19,023 sh
$718.1K
Filed 09/03
Traded 09/03
Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.3M
29,208 sh
$1.3M
Filed 06/26
Traded 06/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
29,208 sh
$1.2M
Filed 06/25
Traded 06/25